Gossamer Bio
CA - San DiegoBiotechnology
Focus: Gossamer Bio is a San Diego-based small-molecule biotech focused on immunology and oncology with a diversified pipeline across respiratory, cardiovascular, GI, and CNS indications. The company is in clinical-stage development with 12 active trials spanning Phase 1–3.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Gossamer Bio?
AI assessmentHigh-risk, high-reward opportunity best suited for candidates with tolerance for clinical volatility and restructuring; pipeline depth is real but recent layoffs signal survival mode.
Why Work Here
- Diversified pipeline with 3 Phase 3 programs (Seralutinib in PAH, GB001 in respiratory) offering near-term clinical catalysts and potential value inflection points.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for Gossamer Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.